Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesKynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controlsThe Neurobiology of Bipolar Disorder: An Integrated ApproachKynurenine pathway metabolites and suicidalityThe role of inflammation in suicidal behaviourThe 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouseStructure, expression, and function of kynurenine aminotransferases in human and rodent brainsBiochemical identification and crystal structure of kynurenine formamidase from Drosophila melanogasterStructure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing InteractionsMeta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophreniaElevated cerebrospinal fluid kynurenic acid levels in patients with tick-borne encephalitisBehavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid.Role of the NMDA-receptor in Prepulse Inhibition in the Rat.Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice.Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.Kynurenines: from the perspective of major psychiatric disorders.Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.Potato- an important source of nutritional kynurenic acidEndurance exercise increases skeletal muscle kynurenine aminotransferases and plasma kynurenic acid in humans.Ketogenic diet increases concentrations of kynurenic acid in discrete brain structures of young and adult rats.Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.Connecting inflammation with glutamate agonism in suicidality.The possible role of the kynurenine pathway in anhedonia in adolescents.Kynurenic Acid in the digestive system-new facts, new challenges.Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic TargetsThe effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia.Sustained elevation of kynurenic Acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis.The association between negative affect and prescription opioid misuse in patients with chronic pain: the mediating role of opioid craving.Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention.The Current Status of the Ketogenic Diet in Psychiatry.A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain.Medicinal chemistry of competitive kainate receptor antagonists.Glutamate neurocircuitry: theoretical underpinnings in schizophrenia.Anticonvulsive evaluation of THIP in the murine pentylenetetrazole kindling model: lack of anticonvulsive effect of THIP despite functional δ-subunit-containing GABAA receptors in dentate gyrus granule cells.Suicidality and Activation of the Kynurenine Pathway of Tryptophan Metabolism.Kynurenines and Glutamate: Multiple Links and Therapeutic Implications.Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia.Chronic Antipsychotic Treatment in the Rat - Effects on Brain Interleukin-8 and Kynurenic Acid.
P2860
Q21129356-F6C3559E-BEE3-4085-A057-D56BC090804BQ24623659-B4F35B04-C7A2-465A-A9B5-BAB08B81E4B7Q26766633-00073E05-2C45-43AD-AB33-0F052F01E745Q26773067-E58B2D90-B7F9-45E2-9E87-02ECE76C7925Q26800426-08BA1679-B4CB-44B3-ADB1-8FC9CC3C63C3Q26849351-B5C37625-1BEB-4373-BC76-F6B1B40A68C3Q27657768-E017C92D-06DC-40D2-8F0D-019FD927B8D3Q27681115-8A25DE22-F945-442C-A39D-1BC705CF22B6Q27684159-9CBDF9D8-3A0E-46D4-8BC1-B391C268C00AQ28248687-4F0961AC-1EDF-4254-9257-0D747C8951F1Q28262656-C2579A0E-2C44-4D29-B936-927187CA3695Q30419650-D709A011-8D39-425D-8210-089A003BB575Q30472936-A144A27F-2FD2-4E27-9F03-1269583F1BC5Q30531298-D8286767-9EB9-4190-8361-A775B1C907EAQ33816563-FB73F6AE-A632-48A7-89D7-01A5CB163452Q34260092-E5A13A93-7CAF-46EF-9BA5-B86EB9CE4A61Q35162796-5FC6FE5A-65EF-4FE0-9514-21B284B2DA02Q35831201-1ECD766C-9581-433A-A2D0-B609B79F6DEBQ35974760-03A4BBFE-8EA8-4F18-A5AB-E7F1D150EDD1Q35985369-6D4CB3D9-5057-4742-9FF2-D2C61A0F6E30Q36623248-7DC18463-F495-46DB-AC59-2A271C354557Q36901111-048AD9DF-D615-450F-9780-CE6C83EA5730Q36921329-FCBC9FFF-2E2A-4DAE-A81E-21979B1D20DAQ37170524-26E77B13-32AC-4ED3-A29E-EACA8BE5EE22Q37310546-91B34F7A-435E-46C0-A5BA-E5269D30C93FQ37351984-02AC0F22-343A-413F-A005-F0FDF38B0358Q37373503-D8E0B0B7-8C03-477E-B2DB-77AF1AA5B325Q37423491-50E6B936-88ED-466F-A01B-1A690065643CQ37580309-294DBFFF-083B-4C1A-A567-019994977415Q37705451-364B3166-1BF1-4896-B313-3BEC438FE22BQ37710385-652820AA-D0CD-4A5D-A101-89104258CA23Q37727201-ABF6DAA5-0B4A-4BA4-84FF-8B7BB84711F3Q38025106-81C8B540-C603-4B6D-BE65-9C82A1A175CDQ38063195-8AF0E299-9B0E-458C-8AEC-126DE53CFE73Q38626006-A61CBE21-98A1-47A5-B514-C44928739682Q38843530-997E1F18-22B0-45B5-A592-C81F4AD55644Q38861843-18357BF0-B8A1-4F6E-BC7D-F4C4C879F7C7Q39130393-5A2C39A3-960F-4116-8BA1-8233220392D4Q39736371-E8205554-C138-4F78-A89A-AE50BA1DEA79Q40452897-3B73C626-0BD1-4984-B058-368BF37FC026
P2860
Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacological manipulation o ...... ment of psychiatric disorders.
@en
Pharmacological manipulation o ...... ment of psychiatric disorders.
@nl
type
label
Pharmacological manipulation o ...... ment of psychiatric disorders.
@en
Pharmacological manipulation o ...... ment of psychiatric disorders.
@nl
prefLabel
Pharmacological manipulation o ...... ment of psychiatric disorders.
@en
Pharmacological manipulation o ...... ment of psychiatric disorders.
@nl
P2860
P1433
P1476
Pharmacological manipulation o ...... ment of psychiatric disorders.
@en
P2093
Göran Engberg
Sara K Olsson
P2860
P304
P356
10.2165/00023210-200923020-00001
P577
2009-01-01T00:00:00Z
P6179
1017091829